Federal award
TEVA PHARMACEUTICALS USA, INC.
SPE2DP23F5009
Contract
Obligated and Ceiling
- Obligated (net)
- $610,787.52
- Ceiling (potential value, not spending)
- $610,787.52
- Current value
- $610,787.52
- Gross positive obligations
- $610,787.52
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- TEVA PHARMACEUTICALS USA, INC. · NEN9A34LRHJ5
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- TEVA PHARMACEUTICAL INDUSTRIES LTD. · DYLJM9RQJ167
- Awarding agency
- Department of Defense · sub-agency 97AS · office SPE2DP
- Funding agency
- Department of Defense · sub-agency 97AS
- Product or service (PSC)
- 6505 · DRUGS AND BIOLOGICALS
- Industry (NAICS)
- 325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
- PIID
- SPE2DP23F5009
- Parent vehicle (IDV PIID)
- SPE2DP20D0002
- Award type code
- C
- Actions
- 1 · Jul 17, 2023 to Jul 17, 2023
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History1
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jul 17, 2023 | FY2023 | 0 | — | $610,787.52 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.